Format

Send to

Choose Destination
Br J Cancer. 1989 Aug;60(2):236-7.

Drug acetylation in breast cancer.

Author information

1
Department of Surgery, University of Wales College of Medicine, Llandough Hospital, Penarth, South Glamorgan, UK.

Abstract

The acetylator phenotype was determined in 100 patients with breast cancer and 100 control female subjects using isoniazid. The proportion of fast acetylators in the breast cancer patients (43%) was not significantly different from the control group (43%). We conclude that acetylator phenotype is unlikely to be an important determinant of the risk of developing breast cancer.

PMID:
2765373
PMCID:
PMC2247050
DOI:
10.1038/bjc.1989.260
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center